Investigation of efficacy of treatment in spinal cord injury: Erythropoietin versus methylprednisolone.

BACKGROUND Investigation of the expression of platelet-derived growth factor (PDGF)-β and glial fibrillary acidic protein (GFAP) in rats with spinal cord injury as a marker of neurologic recovery between groups treated with erythropoietin (EPO) and methylprednisolone (MP). METHODS Thirty adult female rats were randomly divided into three even groups. A… CONTINUE READING